East Anglian audit of pembrolizumab in non-small cell lung cancer

被引：0
|
作者：
Jackson, A. H. [1 ]
Fenn, R. [2 ]
Shotton, R. [3 ]
Williams, A. [1 ]
Treece, S. [4 ]
Gkogkou, P. [2 ]
Tasigiannopoulos, Z. [2 ]
Gilligan, D. [5 ]
Yip, K. [1 ]
机构：
[1] Ipswich Hosp, Oncol, Ipswich, Suffolk, England
[2] Nofolk & Norwich Univ Hosp, Oncol, Norwich, Norfolk, England
[3] Cambridge Univ Hosp, Oncol, Cambridge, England
[4] Peterborough City Hosp, Oncol, Peterborough, Cambs, England
[5] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England
来源：
LUNG CANCER | 2018年 / 115卷
关键词：
D O I：
10.1016/S0169-5002(18)30120-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
94
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence
    Rihawi, Karim
    Gelsomino, Francesco
    Sperandi, Francesca
    Melotti, Barbara
    Fiorentino, Michelangelo
    Casolari, Laura
    Ardizzoni, Andrea
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (09) : 353 - 373
  • [32] Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments
    Gower, Arjan
    Garon, Edward B.
    TRANSLATIONAL CANCER RESEARCH, 2022,
  • [33] The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer
    Alexander, Mariam
    Ko, Brian
    Lambert, Remy
    Gadgeel, Shirish
    Halmos, Balazs
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 137 - 147
  • [34] Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
    Burgos-San Jose, Amparo
    Colomer-Aguilar, Claudia
    Martinez-Caballero, Daniel
    Massuti-Sureda, Bartomeu
    FARMACIA HOSPITALARIA, 2021, 45 (03) : 121 - 125
  • [35] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [36] Trousseau's syndrome in a non-small cell lung cancer patient aggravated by pembrolizumab
    Zhao, Lihong
    Zheng, Hong
    Zhu, Liqin
    Jiang, Ping
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 233 - 238
  • [37] Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    BIODRUGS, 2016, 30 (05) : 397 - 405
  • [38] Non-small cell lung cancer
    Nestle, U.
    Hoffmann, H.
    Reck, M.
    Bruns, C.
    ONKOLOGIE, 2022, 28 (12): : 1034 - 1037
  • [39] Non-small cell lung cancer
    Hill, Andrew
    Fisher, Patricia
    Yeomanson, Dan
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [40] Non-small cell lung cancer
    Besse, B.
    Vignot, S.
    ONCOLOGIE, 2013, 15 (7-8) : 371 - 376
12345